VTSI.NASDAQVirtra, INC

DEF 14A: VirTra Sets 2025 Annual Meeting, Board Elections

Sentiment:

Proxy Statement


VirTra, Inc. announced its 2025 Annual Meeting of Stockholders to be held on October 14, 2025, to elect five directors and ratify the appointment of Haynie & Company as its independent registered public accounting firm.

Summary

  • The Annual Meeting of Stockholders is scheduled for Tuesday, October 14, 2025, at 1:30 p.m. local time (4:30 p.m. Eastern Time).
  • Stockholders will vote on the election of five directors to the Board and the ratification of Haynie & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
  • The record date for voting eligibility is August 18, 2025, with 11,268,212 shares of common stock outstanding.
  • The Board of Directors recommends voting FOR the election of all five director nominees and FOR the ratification of Haynie & Company.
  • Executive compensation for 2024 included John F. Givens II (CEO) with $1,204,095 total, Alanna Boudreau (CFO) with $307,921 total, and former Executive Chairman Robert D. Ferris with $1,213,133 total.
  • Non-employee directors receive $2,500 per month quarterly, plus annual grants of restricted stock units (2,000 RSUs plus additional units for committee service).
  • The company's profit-sharing program expense decreased significantly from $1,260,431 in 2023 to $216,255 in 2024.
  • Audit fees for Haynie & Company were $127,012 in 2024, an increase from $111,204 in 2023.

Sentiment

Score: 6

Explanation: The filing is a routine proxy statement, primarily focused on corporate governance and annual meeting procedures. The positive additions to the board and robust governance policies are favorable, but the delinquent Section 16(a) reports and significant drop in profit-sharing expense introduce minor concerns, balancing the overall sentiment to slightly positive/neutral.

Positives

  • The Board of Directors has a majority of independent directors, enhancing corporate oversight and adherence to NASDAQ listing standards.
  • Established three standing committees (Audit, Compensation, and Nominating and Corporate Governance) with independent chairs, providing specialized oversight.
  • Adopted a Code of Ethics, Whistleblower Protection Policy, and Insider Trading Policy, demonstrating a commitment to ethical conduct and compliance.
  • Lt. Gen.(R) Maria R. Gervais, a new director, brings extensive experience in military simulation, virtual/gaming, and training domains, which is highly relevant to the company's military sales expansion initiatives.
  • Mr. Michael T. Ayers, a new director, brings over 35 years of law enforcement experience, which can contribute to the development and delivery of better training products.

Negatives

  • Mr. Jeffrey Brown and Ms. Alanna Boudreau had delinquent Section 16(a) reports in 2024, indicating a lapse in timely regulatory filings.
  • The profit-sharing program expense significantly decreased from $1,260,431 in 2023 to $216,255 in 2024, which could imply lower company profitability or a reduction in employee bonus allocations.

Risks

  • Financial risks, which are overseen by the Audit Committee.
  • Product commercialization risks, regularly reviewed by the Board of Directors.
  • Compensation programs potentially creating incentives for employees to take excessive or inappropriate risks, which could have a material adverse effect on the company, overseen by the Compensation Committee.

Future Outlook

The company expects to announce preliminary voting results at the Annual Meeting and plans to publish final results in a Current Report on Form 8-K within four business days. If final results are not available, a preliminary Form 8-K will be filed, followed by an amendment with final results. The Audit Committee will consider stockholder feedback on auditor ratification and may select a different firm if deemed in the company's best interest, even if the current appointment is ratified.

Management Comments

  • The Board of Directors urges stockholders to promptly execute and return their proxy, even if they plan to attend the Annual Meeting virtually or in-person.
  • The Board of Directors recommends voting FOR each of the nominees to the Board of Directors and FOR ratification of the appointment of Haynie & Company.
  • The company is not aware of any other matters that will be voted on at the 2025 Annual Meeting.

Industry Context

The appointment of Lt. Gen.(R) Maria R. Gervais, a leader in military simulation and training, and Mr. Michael T. Ayers, with extensive law enforcement experience, aligns VirTra's board with its core business of providing simulation and training products. This strategic board composition is crucial for navigating the defense and law enforcement sectors, which are key markets for the company's offerings, and supports its military sales expansion initiatives.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks. Therefore, a direct comparison to industry standards is not possible based solely on the information provided.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the BoardN/AJohn F. Givens IIJuly 2024Appointment to Board Chair.
Executive ChairmanRobert D. FerrisN/AJuly 12, 2024Resignation.
DirectorJames McDonnellN/AOctober 21, 2024Served until this date.
DirectorN/AMichael T. AyersOctober 21, 2024Commenced serving on the board.
DirectorN/ALt. Gen.(R) Maria R. GervaisOctober 21, 2024Commenced serving on the board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board consists of five directors, with a majority determined to be independent under NASDAQ listing standards.As of August 26, 2025Enhances independent oversight and aligns with best practices for public companies.
Board Leadership StructureJohn F. Givens II serves as both Chairman of the Board and Chief Executive Officer. The Board periodically reviews its leadership structure and holds executive sessions with only independent directors.July 2024 (Chairman appointment)Combines leadership roles, but independent director majority and executive sessions provide checks and balances.
Committee StructureEstablished Audit, Compensation, and Nominating and Corporate Governance Committees, each operating under a Board-approved charter and meeting NASDAQ Listing Rules.N/A (established)Provides specialized oversight for financial reporting, executive compensation, and director selection, improving governance effectiveness.
Policies AdoptionAdopted a written Code of Ethics and Business Conduct, a Whistleblower Protection Policy, and an Insider Trading Policy.N/A (adopted)Strengthens ethical conduct, protects employees reporting misconduct, and promotes compliance with securities laws.
Director CompensationNon-employee directors receive $2,500 per month quarterly, plus annual grants of 2,000 restricted stock units and additional units for committee service (500 for members, 1,000 for chairs).July 1, 2024Provides competitive compensation to attract and retain qualified independent directors, aligning their interests with stockholders through equity awards.

Legal Proceedings

  • None of the directors, executive officers, significant employees, or control persons have been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past 10 years.

Related Party Transactions

  • Redemption of 10,000 previously awarded stock options from former Executive Chairman Robert D. Ferris for $59,600 in 2024.
  • Redemption of 15,000 previously awarded stock options from former Executive Chairman Robert D. Ferris for $29,251 in 2023.
  • Exercise of 5,000 previously awarded options by related parties (former Executive Chair and one director) for $20,150 in 2024.
  • Exercise of 15,000 previously awarded options by related parties (former Executive Chair and one director) for $54,900 in 2023.

Stakeholder Impact

  • Shareholders will vote on key governance matters (director elections, auditor ratification) and are provided transparency on executive and director compensation, and corporate governance practices.
  • Employees are affected by the discretionary profit-sharing program, which saw a significant decrease in expensed amount in 2024, and are covered by the Equity Incentive Plan, Code of Ethics, and Whistleblower Protection Policy.
  • Management and Directors have their compensation details disclosed, and new directors bring relevant industry expertise, potentially influencing strategic direction.

Next Steps

  • Stockholders are encouraged to submit proxies or vote at the Annual Meeting on October 14, 2025.
  • The company will hold its Annual Meeting on October 14, 2025, to elect directors and ratify the auditor.
  • The company will publish preliminary and final voting results in a Form 8-K following the Annual Meeting.
  • Stockholders can submit proposals for the 2026 Annual Meeting between June 16, 2026, and July 16, 2026.

Key Dates

DateDescription
2009Stock option compensation plan approved by the Board of Directors.
2011Jeffrey D. Brown commenced serving as a director.
March 9, 2016Board of Directors approved a program for repurchasing outstanding vested Company stock options on an exception basis.
May 2016Gregg C.E. Johnson served as corporate secretary and a director of Vivos Biotechnologies, Inc.
October 6, 2017VirTra, Inc. 2017 Equity Incentive Plan approved by stockholders.
October 1, 2017Stock option awards suspended.
January 2017Gregg C.E. Johnson was CEO of Upeva, Inc.
October 2017Lt. Gen.(R) Maria R. Gervais served as the first Synthetic Training Environment Cross Functional Team Director.
March 2018Gregg C.E. Johnson ceased serving as corporate secretary and a director of Vivos Biotechnologies, Inc.
January 2019Michael T. Ayers became Executive Director of the Georgia Peace Officer Standards and Training Council.
November 2, 2020John F. Givens II commenced serving as a director.
April 11, 2022John F. Givens II appointed Co-Chief Executive Officer.
October 2021Gregg C.E. Johnson was a director and CEO of Serenus Global Inc.
November 2021Gregg C.E. Johnson ceased being CEO of Upeva, Inc.
December 2022Alanna Boudreau appointed Chief Financial Officer.
November 2022Gregg C.E. Johnson commenced serving as a director.
August 15, 2023John F. Givens II appointed Chief Executive Officer; employment agreement effective. Robert D. Ferris became Executive Chairman.
October 2023John F. Givens II issued 133,333 shares upon settlement of restricted stock units.
February 2024Gregg C.E. Johnson ceased being a director and CEO of Serenus Global Inc.
July 1, 2024Non-employee director compensation structure changed to $2,500 per month plus restricted stock units.
July 12, 2024Robert D. Ferris resigned as Executive Chairman.
July 2024John F. Givens II became Board Chair.
August 2024Lt. Gen.(R) Maria R. Gervais retired from the U.S. Army.
October 21, 2024James McDonnell served until this date. Michael T. Ayers and Lt. Gen.(R) Maria R. Gervais commenced serving on the board.
December 31, 2024Fiscal year end for which Haynie & Company acted as independent registered public accounting firm and for which compensation data is reported.
August 18, 2025Record Date for stockholders entitled to notice of, and to vote at, the Annual Meeting.
August 26, 2025Date of the Notice of Annual Meeting and Proxy Statement.
October 13, 2025Deadline for Internet and mail proxy voting (11:59 p.m. Eastern Time).
October 14, 2025Date of the Annual Meeting of Stockholders.
December 31, 2025Fiscal year end for which Haynie & Company is appointed as independent registered public accounting firm.
June 16, 2026Earliest date for stockholder proposals for the 2026 Annual Meeting to be received for inclusion in proxy statement.
July 16, 2026Latest date for stockholder proposals for the 2026 Annual Meeting to be received for inclusion in proxy statement.

Recommendation

hold

This is a routine proxy statement detailing annual meeting proposals, corporate governance, and executive compensation. While the addition of highly experienced directors and robust governance policies are positive, the delinquent Section 16(a) reports and a substantial decrease in profit-sharing expense introduce minor concerns. There is no new material financial or strategic information that would warrant a strong buy or sell recommendation; therefore, a 'hold' recommendation is appropriate as investors await further operational and financial updates.

Keywords

VirTra, VTSI, Proxy Statement, Annual Meeting, Board of Directors, Corporate Governance, Executive Compensation, Auditor Ratification, SEC Filing, Stockholder Vote, Simulation Training, Defense Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.